keyword
https://read.qxmd.com/read/38649941/surgical-management-of-renal-cell-carcinoma-with-subhepatic-inferior-vena-cava-tumor-thrombus-a-case-report-and-review-of-the-literature
#1
JOURNAL ARTICLE
Bekim Ademi, Luan Jaha, Isa Haxhiu, Xhevdet Çuni, Afrim Tahiri, Jetmir Gashi, Adhurim Koshi, Art Jaha
BACKGROUND: Renal cell carcinomas are the most common form of kidney cancer in adults. In addition to metastasizing in lungs, soft tissues, bones, and the liver, it also spreads locally. In 2-10% of patients, it causes a thrombus in the renal or inferior vena cava vein; in 1% of patients thrombus reaches the right atrium. Surgery is the only curative option, particularly for locally advanced disease. Despite the advancements in laparoscopic, robotic and endovascular techniques, for this group of patients, open surgery continues to be among the best options...
April 23, 2024: Journal of Medical Case Reports
https://read.qxmd.com/read/38639385/diagnostic-performance-of-18f-fdg-positron-emission-tomography-computed-tomography-and-blood-test-parameters-for-pulmonary-inflammatory-pseudotumor
#2
JOURNAL ARTICLE
Bo Pan, Yanming Wang, Zehua Zhu, Xingxing Zhu
PURPOSE: Pulmonary inflammatory pseudotumor (PIP) is an inflammatory proliferative tumor-like lesion that frequently exhibits hypermetabolism on 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography imaging (PET/CT) and is readily misdiagnosed as a malignant tumor. The purpose of this study was to identify PIP by combining PET/computed tomography metabolic and blood test characteristics with machine learning. PATIENTS AND METHODS: We recruited 27 patients with PIP and 28 patients with lung cancer (LC)...
April 18, 2024: Journal of Thoracic Imaging
https://read.qxmd.com/read/38636630/preoperative-blood-counts-predict-overall-survival-in-patients-undergoing-surgical-removal-of-brain-metastasis
#3
JOURNAL ARTICLE
Ryosuke Matsuda, Ryosuke Maeoka, Takayuki Morimoto, Tsutomu Nakazawa, Yudai Morisaki, Kenta Nakase, Shohei Yokoyama, Masashi Kotsugi, Yasuhiro Takeshima, Shuichi Yamada, Ichiro Nakagawa
OBJECTIVE: The prognosis for patients with cancer with brain metastasis (BM) requiring surgical removal is quite limited. Preoperative prognostic factors can provide meaningful information to surgeons, oncologists, and patients. This study evaluated the preoperative blood counts in patients with BM who were treated with surgical removal. METHODS: Between January 2011 and November 2021, 221 consecutive surgeries were conducted on 198 patients with BM. Among the 198 patients, 188 patients with sufficient blood test data and follow-up were analyzed in this study...
April 16, 2024: World Neurosurgery
https://read.qxmd.com/read/38632333/a-multi-cancer-early-detection-blood-test-using-machine-learning-detects-early-stage-cancers-lacking-uspstf-recommended-screening
#4
JOURNAL ARTICLE
Janet Vittone, David Gill, Alex Goldsmith, Eric A Klein, Jordan J Karlitz
US Preventive Services Task Force (USPSTF) guidelines recommend single-cancer screening for select cancers (e.g., breast, cervical, colorectal, lung). Advances in genome sequencing and machine learning have facilitated the development of blood-based multi-cancer early detection (MCED) tests intended to complement single-cancer screening. MCED tests can interrogate circulating cell-free DNA to detect a shared cancer signal across multiple tumor types. We report real-world experience with an MCED test that detected cancer signals in three individuals subsequently diagnosed with cancers of the ovary, kidney, and head/neck that lack USPSTF-recommended screening...
April 17, 2024: NPJ Precision Oncology
https://read.qxmd.com/read/38617760/outcomes-of-oncological-intended-thoracic-surgery-after-lung-transplantation
#5
JOURNAL ARTICLE
Armin Frille, Johannes Broschewitz, Isabella Bettine Metelmann, Matthias Steinert, Maximilian von Laffert, Hubert Wirtz, Alexandra Wald, Sebastian Kraemer
BACKGROUND: Lung cancer following lung transplantation (LT) may require thoracic surgery (TS). There is an urgent need for data on surgical feasibility, clinical and surgical characteristics, as well as outcome data. METHODS: We reviewed the medical records of LT patients who had undergone TS at the University Hospital Leipzig between the years 2000 and 2022. Data on medical and surgical history, pulmonary function test, arterial blood gas analysis, six-minute walking distance test, and surgical approach, perioperative management, anesthesiologic, and surgical procedures were analyzed...
March 29, 2024: Journal of Thoracic Disease
https://read.qxmd.com/read/38615459/surface-enhanced-raman-scattering-based-identification-of-breast-cancer-progression-using-extracellular-vesicles-derived-integrin-%C3%AE-6%C3%AE-4
#6
JOURNAL ARTICLE
Haozhi Lei, Haoze Wang, Xiqiu Wang, Zeyu Xiao, Tian Tian, Kai Cui
Detection of progression is of great importance to breast cancer treatment and can benefit patients. Limited by current detection technologies and biomarkers, early breast cancer progression diagnosis remains challenging. Researchers have found blood extracellular vesicles (EVs)-derived integrin α6β4 directly facilitate progression in breast cancer, enabling cancer detection. However, EVs size and heterogeneity hinder protein detection, masked by abundant background EVs. Hence, novel tools for efficient detection of EVs with high selectivity and low interference are significantly desired...
April 13, 2024: Talanta
https://read.qxmd.com/read/38603624/increasing-power-in-screening-trials-by-testing-control-arm-specimens-application-to-multicancer-detection-screening
#7
JOURNAL ARTICLE
Hormuzd A Katki, Philip C Prorok, Philip E Castle, Lori M Minasian, Paul F Pinsky
BACKGROUND: Cancer screening trials have required large sample-sizes and long time-horizons to demonstrate cancer mortality reductions, the primary goal of cancer screening. We examine assumptions and potential power gains from exploiting information from testing control-arm specimens, which we call the "Intended Effect" (IE) analysis that we explain in detail herein. The IE analysis is particularly suited to tests that can be conducted on stored specimens in the control-arm, such as stored blood for multicancer detection (MCD) tests...
April 11, 2024: Journal of the National Cancer Institute
https://read.qxmd.com/read/38601686/application-of-artificial-intelligence-in-the-diagnosis-treatment-and-recurrence-prediction-of-peritoneal-carcinomatosis
#8
REVIEW
Gui-Xia Wei, Yu-Wen Zhou, Zhi-Ping Li, Meng Qiu
Peritoneal carcinomatosis (PC) is a type of secondary cancer which is not sensitive to conventional intravenous chemotherapy. Treatment strategies for PC are usually palliative rather than curative. Recently, artificial intelligence (AI) has been widely used in the medical field, making the early diagnosis, individualized treatment, and accurate prognostic evaluation of various cancers, including mediastinal malignancies, colorectal cancer, lung cancer more feasible. As a branch of computer science, AI specializes in image recognition, speech recognition, automatic large-scale data extraction and output...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38594545/in-vivo-labeling-and-detection-of-circulating-tumor-cells-in-mice-using-otl38
#9
JOURNAL ARTICLE
Joshua Pace, Jane J Lee, Madduri Srinivasarao, Shivakrishna Kallepu, Philip S Low, Mark Niedre
PURPOSE: We recently developed an optical instrument to non-invasively detect fluorescently labeled circulating tumor cells (CTCs) in mice called 'Diffuse in vivo Flow Cytometry' (DiFC). OTL38 is a folate receptor (FR) targeted near-infrared (NIR) contrast agent that is FDA approved for use in fluorescence guided surgery of ovarian and lung cancer. In this work, we investigated the use OTL38 for in vivo labeling and detection of FR + CTCs with DiFC. PROCEDURES: We tested OTL38 labeling of FR + cancer cell lines (IGROV-1 and L1210A) as well as FR- MM...
April 9, 2024: Molecular Imaging and Biology: MIB: the Official Publication of the Academy of Molecular Imaging
https://read.qxmd.com/read/38593164/performance-characteristics-of-a-polymerase-chain-reaction-based-assay-for-the-detection-of-egfr-mutations-in-plasma-cell-free-dna-from-patients-with-non-small-cell-lung-cancer-using-cell-free-dna-collection-tubes
#10
JOURNAL ARTICLE
Theresa May, Michelle S Clement, Harkanwal Halait, Alexander Kohlmann, Milena Kohlmann, Jason Lai, Nitta Lee, Xiaocheng Li-Sucholeiki, Peter Meldgaard, Snehal Joshi, Sidney Scudder, Neelima Shrestha, Boe Sorensen, Marilyn Kiral, Patrick O'Donnell
Survival rates in non-small cell lung cancer (NSCLC) are low. Detection of circulating tumor DNA in liquid biopsy (plasma) is increasingly used to identify targeted therapies for clinically actionable mutations, including EGFR mutations in NSCLC. The cobas® EGFR Mutation Test v2 (cobas EGFR test) is FDA-approved for EGFR mutation detection in tissue or liquid biopsy from NSCLC. Standard K2EDTA tubes require plasma separation from blood within 4 to 8 hours; however, Roche Cell-Free DNA (cfDNA) Collection Tubes (Roche cfDNA tube) enable whole blood stability for up to 7 days prior to plasma separation...
2024: PloS One
https://read.qxmd.com/read/38590595/the-prognostic-significance-of-pretreatment-white-blood-cell-and-platelet-counts-for-survival-outcome-in-primary-lung-cancer
#11
JOURNAL ARTICLE
Vo-Van Kha, Tran-Thi Huong Ly, Phan Duong Thanh Duy, Pham-Thi Thanh Hoa, Bui Tien Cong
BACKGROUND: In Vietnam, lung cancer ranks second among common types of cancer. Although there have been many advances in the diagnosis and treatment of lung cancer, it is still one of the deadliest types of cancer. OBJECTIVE: We investigated the prognostic value of pretreatment white blood cell (WBC) and platelet counts of patients with lung cancer. METHODS: This was a prospective, descriptive study with longitudinal follow-up. Data from 203 patients with stage IIIA-IV lung cancer presenting at Can Tho City Oncology Hospital between June 2020 and June 2022 were analyzed...
2024: Materia Socio-medica
https://read.qxmd.com/read/38584122/the-impact-of-egfr-t790m-mutation-status-following-the-development-of-osimertinib-resistance-on-the-efficacy-of-osimertinib-in-non-small-cell-lung-cancer-a-meta-analysis
#12
REVIEW
Liuxian Guo, Guojin Zhou, Min Huang, Kejing Tang, Jing Xu, Jie Chen
BACKGROUND: Previous studies have suggested that loss of the EGFR T790M gene mutation may contribute to the development of resistance to Osimertinib in non-small cell lung cancer (NSCLC). AIMS: This study aims to assess the relationship between the clinical effectiveness of Osimertinib in NSCLC patients and the T790M mutation status following resistance to Osimertinib and examine differences between plasma and tissue tests and between Asian and non-Asian groups...
April 2024: Clinical Respiratory Journal
https://read.qxmd.com/read/38581401/uncommon-pathogen-misidentification-of-herbaspirillum-huttiense-as-burkholderia-cepacia-in-bacteremia-a-case-report
#13
JOURNAL ARTICLE
Qun Wang, Xinjian Cai, Li Zhang
Herbaspirillum huttiense is an opportunistic pathogen associated with rare cases of bacteremia. In this case report, H huttiense was isolated from blood samples collected from an intravenous catheter (incubated for 20.8 hours) and a peripheral vein (incubated for 14.16 hours) of a lung adenocarcinoma patient. Positive blood culture bottles were subjected to smear preparation, and Gram staining and microscopic examination revealed the presence of gram-negative rods in both aerobic bottles. We used the VITEK MS automatic microbial mass spectrometry system, VITEK 2 Compact automatic microbial analysis system, and high-throughput nucleic acid sequencing for accurate identification of the isolate...
April 6, 2024: Laboratory Medicine
https://read.qxmd.com/read/38575804/the-learning-curve-of-a-bronchus-first-method-in-bi-port-video-assisted-thoracoscopic-surgery-for-left-upper-lobe-lung-cancer
#14
JOURNAL ARTICLE
Ge Qu, Heng Zhang, Rulin Qian
Video-assisted thoracic surgery (VATS) has been widely used in lung cancer treatment. However, VATS left upper lobectomy (LUL) is complex due to the intricate branching pattern of the left pulmonary artery (PA). Nevertheless, VATS right upper lobectomy can be simplified through a bronchus-first and simultaneous vessel stapling technique. In this study, the learning curve was obtained while ensuring favorable oncological outcomes using bronchus-first method for VATS LUL. First, retrospective data of 148 consecutive patients who underwent VATS LUL (bronchus-first method) for non-small cell lung cancer (NSCLC) from March 2018 to October 2020 were analyzed...
April 4, 2024: Updates in Surgery
https://read.qxmd.com/read/38564228/a-microfluidics-assisted-double-barreled-nanobioconjugate-synthesis-introducing-aprotinin-as-a-new-moonlight-nanocarrier-protein-tested-toward-physiologically-relevant-3d-spheroid-models
#15
JOURNAL ARTICLE
Faiqa Nazir, Iqra Munir, Gurkan Yesiloz
Proteins are promising substances for introducing new drug carriers with efficient blood circulation due to low possibilities of clearance by macrophages. However, such natural biopolymers have highly sophisticated molecular structures, preventing them from being assembled into nanoplatforms with manipulable payload release profiles. Here, we report a novel anticancer nanodrug carrier moonlighting protein, Aprotinin, to be used as a newly identified carrier for cytotoxic drugs. The Aprotinin-Doxorubicin (Apr-Dox) nanobioconjugate was prepared via a single-step microfluidics coflow mixing technique, a feasible and simple way to synthesize a carrier-based drug design with a double-barreled approach that can release and actuate two therapeutic agents simultaneously, i...
April 2, 2024: ACS Applied Materials & Interfaces
https://read.qxmd.com/read/38555923/anti-cd30-car-t-cells-as-consolidation-after-autologous-haematopoietic-stem-cell-transplantation-in-patients-with-high-risk-cd30-lymphoma-a-phase-1-study
#16
JOURNAL ARTICLE
Natalie S Grover, George Hucks, Marcie L Riches, Anastasia Ivanova, Dominic T Moore, Thomas C Shea, Mary Beth Seegars, Paul M Armistead, Kimberly A Kasow, Anne W Beaven, Christopher Dittus, James M Coghill, Katarzyna J Jamieson, Benjamin G Vincent, William A Wood, Catherine Cheng, Julia Kaitlin Morrison, John West, Tammy Cavallo, Gianpietro Dotti, Jonathan S Serody, Barbara Savoldo
BACKGROUND: Chimeric antigen receptor (CAR) T cells targeting CD30 are safe and have promising activity when preceded by lymphodepleting chemotherapy. We aimed to determine the safety of anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation (HSCT) in patients with CD30+ lymphoma at high risk of relapse. METHODS: This phase 1 dose-escalation study was performed at two sites in the USA. Patients aged 3 years and older, with classical Hodgkin lymphoma or non-Hodgkin lymphoma with CD30+ disease documented by immunohistochemistry, and a Karnofsky performance score of more than 60% planned for autologous HSCT were eligible if they were considered high risk for relapse as defined by primary refractory disease or relapse within 12 months of initial therapy or extranodal involvement at the start of pre-transplantation salvage therapy...
March 28, 2024: Lancet Haematology
https://read.qxmd.com/read/38555313/the-prognostic-value-and-model-construction-of-inflammatory-markers-for-patients-with-non-small-cell-lung-cancer
#17
JOURNAL ARTICLE
Wanting Xu, Xinya Liu, Ci Yan, Gulinurayi Abdurahmane, Jiayina Lazibiek, Yan Zhang, Mingqin Cao
The aim of this study was to investigate and analyse the predictive value of systemic inflammatory markers based on peripheral blood biomarkers for the prognosis of non-small cell lung cancer (NSCLC) patients. Based on a retrospective monitoring cohort of 973 NSCLC patients from an Affiliated Tumor Hospital from 2012 to 2023. The log-rank test and Cox proportional risk regression model were used to identify independent prognostic inflammatory markers. Subsequently, a nomogram prediction model was constructed and evaluated...
March 30, 2024: Scientific Reports
https://read.qxmd.com/read/38554335/association-of-systemic-inflammatory-markers-with-prognosis-in-erlotinib-treated-egfr-mutant-non-small-cell-lung-cancer
#18
JOURNAL ARTICLE
Abdullah Evren Yetişir, Semra Paydaş, Mahmut Büyükşimşek, Ali Oğul, İrem Kolsuz, Mehmet Mutlu Kıdı
BACKGROUND: To evaluate the relationship of overall survival (OS) and progression-free survival (PFS) with the derived neutrophil-lymphocyte ratio (dNLR), neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), and platelet-lymphocyte ratio (PLR) in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). METHODS: The study included 43 patients with EGFR-mutant metastatic NSCLC. The dNLR, NLR, LMR, and PLR values were calculated using the baseline complete blood counts before and after treatment with erlotinib...
January 1, 2024: Journal of Cancer Research and Therapeutics
https://read.qxmd.com/read/38554236/a-prospective-study-of-smoking-related-white-blood-cell-dna-methylation-markers-and-risk-of-bladder-cancer
#19
JOURNAL ARTICLE
Roel Vermeulen, Barbara Bodinier, Sonia Dagnino, Rin Wada, Xuting Wang, Debra Silverman, Demetrius Albanes, Neal Freedman, Mohammad Rahman, Douglas Bell, Marc Chadeau-Hyam, Nathaniel Rothman
Bladder cancer, a common neoplasm, is primarily caused by tobacco smoking. Epigenetic alterations including DNA methylation have the potential to be used as prospective markers of increased risk, particularly in at-risk populations such as smokers. We aimed to investigate the potential of smoking-related white blood cell (WBC) methylation markers to contribute to an increase in bladder cancer risk prediction over classical questionnaire-based smoking metrics (i.e., duration, intensity, packyears) in a nested case-control study within the prospective prostate, lung, colorectal, and ovarian (PLCO) Cancer Screening Trial and the alpha-tocopherol, beta-carotene cancer (ATBC) Prevention Study (789 cases; 849 controls)...
March 30, 2024: European Journal of Epidemiology
https://read.qxmd.com/read/38548347/high-temporal-resolution-kinetic-modeling-of-lung-tumors-with-dual-blood-input-function-using-total-body-dynamic-pet
#20
JOURNAL ARTICLE
Yiran Wang, Yasser G Abdelhafez, Benjamin A Spencer, Rashmi Verma, Mamta Parikh, Nicholas Stollenwerk, Lorenzo Nardo, Terry Jones, Ramsey D Badawi, Simon R Cherry, Guobao Wang
The lungs are supplied by both the pulmonary arteries carrying deoxygenated blood originating from the right ventricle and the bronchial arteries carrying oxygenated blood downstream from the left ventricle. However, this effect of dual blood supply has never been investigated using PET, partially because the temporal resolution of conventional dynamic PET scans is limited. The advent of PET scanners with a long axial field of view, such as the uEXPLORER total-body PET/CT system, permits dynamic imaging with high temporal resolution (HTR)...
March 28, 2024: Journal of Nuclear Medicine
keyword
keyword
24482
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.